Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR51052
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Bessa, Luiza Mamigonian; Guseva, Serafima; Camacho-Zarco, Aldo; Salvi, Nicola; Maurin, Damien; Perez, Laura Marino; Botova, Maiia; Malki, Anas; Nanao, Max; Jensen, Malene Ringkjobing; Ruigrok, Rob; Blackledge, Martin. "The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a" Sci. Adv. 8, eabm4034-eabm4034 (2022).
PubMed: 35044811
Assembly members:
entity_1, polymer, 99 residues, 11255.68 Da.
entity_2, polymer, 114 residues, 12719.34 Da.
entity_3, polymer, 76 residues, 8066 Da.
entity_4, polymer, 76 residues, 8126 Da.
entity_5, polymer, 92 residues, 9601.60 Da.
Natural source: Common Name: SARS-CoV-2 Taxonomy ID: 2697049 Superkingdom: Viruses Kingdom: not available Genus/species: Betacoronavirus HCoV-SARS
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pESPRIT
Entity Sequences (FASTA):
entity_1: GRRQGYKSVNITFELDERID
KVLNEKCSAYTVELGTEVNE
FACVVADAVIKTLQPVSELL
TPLGIDLDEWSMATYYLFDE
SGEFKLASHMYCSFYPPDE
entity_2: GAMAPTKVTFGDDTVIEVQG
YKSVNITFELDERIDKVLNE
KCSAYTVELGTEVNEFACVV
ADAVIKTLQPVSELLTPLGI
DLDEWSMATYYLFDESGEFK
LASHMYCSFYPPDE
entity_3: GRRRNSSRNSTPGSSRGTSP
ARMAGNGGDAALALLLLDRL
NQLESKMSGKGQQQQGQTVT
KKSAAEASKKPRQKRT
entity_4: GRRRNSSRNSTPGSSRGTSP
ARMAGNGGDAALALLLLDRL
NQLESKMFGKGQQQQGQTVT
KKSAAEASKKPRQKRT
entity_5: GRRGSRGGSQASSRSSSRSR
NSSRNSTPGSSRGTSPARMA
GNGGDAALALLLLDRLNQLE
SKMSGKGQQQQGQTVTKKSA
AEASKKPRQKRT
Data type | Count |
13C chemical shifts | 322 |
15N chemical shifts | 156 |
1H chemical shifts | 593 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | SARS-CoV-2 Nsp3, 16-111 | 1 |
2 | SARS-CoV-2 Nsp3, 1-111 | 2 |
3 | SARS-CoV-2 Nucleoprotein, 191-263 | 3 |
4 | SARS-CoV-2 Nucleoprotein, 191-263 S235F | 4 |
5 | SARS-CoV-2 Nucleoprotein, 175-263 | 5 |
Entity 1, SARS-CoV-2 Nsp3, 16-111 99 residues - 11255.68 Da.
Represents residues 16-111 of SARS-CoV-2 Nsp3 with non-native GRR- N-terminal extension.
1 | GLY | ARG | ARG | GLN | GLY | TYR | LYS | SER | VAL | ASN | ||||
2 | ILE | THR | PHE | GLU | LEU | ASP | GLU | ARG | ILE | ASP | ||||
3 | LYS | VAL | LEU | ASN | GLU | LYS | CYS | SER | ALA | TYR | ||||
4 | THR | VAL | GLU | LEU | GLY | THR | GLU | VAL | ASN | GLU | ||||
5 | PHE | ALA | CYS | VAL | VAL | ALA | ASP | ALA | VAL | ILE | ||||
6 | LYS | THR | LEU | GLN | PRO | VAL | SER | GLU | LEU | LEU | ||||
7 | THR | PRO | LEU | GLY | ILE | ASP | LEU | ASP | GLU | TRP | ||||
8 | SER | MET | ALA | THR | TYR | TYR | LEU | PHE | ASP | GLU | ||||
9 | SER | GLY | GLU | PHE | LYS | LEU | ALA | SER | HIS | MET | ||||
10 | TYR | CYS | SER | PHE | TYR | PRO | PRO | ASP | GLU |
Entity 2, SARS-CoV-2 Nsp3, 1-111 114 residues - 12719.34 Da.
Represents residues 1-111 of SARS-CoV-2 Nsp3 with non-native GAM- N-terminal extension
1 | GLY | ALA | MET | ALA | PRO | THR | LYS | VAL | THR | PHE | ||||
2 | GLY | ASP | ASP | THR | VAL | ILE | GLU | VAL | GLN | GLY | ||||
3 | TYR | LYS | SER | VAL | ASN | ILE | THR | PHE | GLU | LEU | ||||
4 | ASP | GLU | ARG | ILE | ASP | LYS | VAL | LEU | ASN | GLU | ||||
5 | LYS | CYS | SER | ALA | TYR | THR | VAL | GLU | LEU | GLY | ||||
6 | THR | GLU | VAL | ASN | GLU | PHE | ALA | CYS | VAL | VAL | ||||
7 | ALA | ASP | ALA | VAL | ILE | LYS | THR | LEU | GLN | PRO | ||||
8 | VAL | SER | GLU | LEU | LEU | THR | PRO | LEU | GLY | ILE | ||||
9 | ASP | LEU | ASP | GLU | TRP | SER | MET | ALA | THR | TYR | ||||
10 | TYR | LEU | PHE | ASP | GLU | SER | GLY | GLU | PHE | LYS | ||||
11 | LEU | ALA | SER | HIS | MET | TYR | CYS | SER | PHE | TYR | ||||
12 | PRO | PRO | ASP | GLU |
Entity 3, SARS-CoV-2 Nucleoprotein, 191-263 76 residues - 8066 Da.
Represents residues 191-263 of SARS-CoV-2 Nucleoprotein with non-native GRR- N-terminal extension.
1 | GLY | ARG | ARG | ARG | ASN | SER | SER | ARG | ASN | SER | ||||
2 | THR | PRO | GLY | SER | SER | ARG | GLY | THR | SER | PRO | ||||
3 | ALA | ARG | MET | ALA | GLY | ASN | GLY | GLY | ASP | ALA | ||||
4 | ALA | LEU | ALA | LEU | LEU | LEU | LEU | ASP | ARG | LEU | ||||
5 | ASN | GLN | LEU | GLU | SER | LYS | MET | SER | GLY | LYS | ||||
6 | GLY | GLN | GLN | GLN | GLN | GLY | GLN | THR | VAL | THR | ||||
7 | LYS | LYS | SER | ALA | ALA | GLU | ALA | SER | LYS | LYS | ||||
8 | PRO | ARG | GLN | LYS | ARG | THR |
Entity 4, SARS-CoV-2 Nucleoprotein, 191-263 S235F 76 residues - 8126 Da.
Represents residues 191-263 of SARS-CoV-2 Nucleoprotein with non-native GRR- N-terminal extension. Contains S235F mutation present in the alpha variant of SARS-CoV-2
1 | GLY | ARG | ARG | ARG | ASN | SER | SER | ARG | ASN | SER | ||||
2 | THR | PRO | GLY | SER | SER | ARG | GLY | THR | SER | PRO | ||||
3 | ALA | ARG | MET | ALA | GLY | ASN | GLY | GLY | ASP | ALA | ||||
4 | ALA | LEU | ALA | LEU | LEU | LEU | LEU | ASP | ARG | LEU | ||||
5 | ASN | GLN | LEU | GLU | SER | LYS | MET | PHE | GLY | LYS | ||||
6 | GLY | GLN | GLN | GLN | GLN | GLY | GLN | THR | VAL | THR | ||||
7 | LYS | LYS | SER | ALA | ALA | GLU | ALA | SER | LYS | LYS | ||||
8 | PRO | ARG | GLN | LYS | ARG | THR |
Entity 5, SARS-CoV-2 Nucleoprotein, 175-263 92 residues - 9601.60 Da.
Represents residues 175-263 of SARS-CoV-2 Nucleoprotein with non-native GRR- N-terminal extension.
1 | GLY | ARG | ARG | GLY | SER | ARG | GLY | GLY | SER | GLN | ||||
2 | ALA | SER | SER | ARG | SER | SER | SER | ARG | SER | ARG | ||||
3 | ASN | SER | SER | ARG | ASN | SER | THR | PRO | GLY | SER | ||||
4 | SER | ARG | GLY | THR | SER | PRO | ALA | ARG | MET | ALA | ||||
5 | GLY | ASN | GLY | GLY | ASP | ALA | ALA | LEU | ALA | LEU | ||||
6 | LEU | LEU | LEU | ASP | ARG | LEU | ASN | GLN | LEU | GLU | ||||
7 | SER | LYS | MET | SER | GLY | LYS | GLY | GLN | GLN | GLN | ||||
8 | GLN | GLY | GLN | THR | VAL | THR | LYS | LYS | SER | ALA | ||||
9 | ALA | GLU | ALA | SER | LYS | LYS | PRO | ARG | GLN | LYS | ||||
10 | ARG | THR |
sample_1: SARS-CoV-2 Nsp3 1-111, [U-13C; U-15N; U-2H], 320 uM; SARS-CoV-2 N 175-263 640 uM; sodium phosphate 50 mM; sodium chloride 250 mM; DTT 2 mM; D2O, [U-99% 2H], 10%
sample_2: SARS-CoV-2 Nucleoprotein 175-263, [U-13C; U-15N; U-2H], 600 uM; SARS-CoV-2 Nsp3 1-111 1200 uM; sodium phosphate 50 mM; sodium chloride 250 mM; DTT 2 mM; D2O, [U-99% 2H], 10%
sample_3: SARS-CoV-2 Nsp3 16-111, [U-99% 13C; U-99% 15N], 200 uM; SARS-CoV-2 Nucleoprotein 191-263 200 uM; sodium phosphate 50 mM; sodium chloride 250 mM; DTT 2 mM; D2O, [U-99% 2H], 10%
sample_4: SARS-CoV-2 Nsp3 16-111, [U-99% 13C; U-99% 15N], 500 uM; SARS-CoV-2 Nucleoprotein 191-263 550 uM; sodium phosphate 50 mM; sodium chloride 250 mM; DTT 2 mM; D2O, [U-99% 2H], 10%
sample_5: SARS-CoV-2 Nucleoprotein 191-263, [U-99% 13C; U-99% 15N], 500 uM; SARS-CoV-2 Nsp3 16-111 550 uM; sodium phosphate 50 mM; sodium chloride 250 mM; DTT 2 mM; D2O, [U-99% 2H], 10%
sample_6: SARS-CoV-2 Nucleoprotein 191-263 S235F, [U-99% 13C; U-99% 15N], 500 uM; SARS-CoV-2 Nsp3 16-111 550 uM; sodium phosphate 50 mM; sodium chloride 250 mM; DTT 2 mM; D2O, [U-99% 2H], 10%
sample_7: SARS-CoV-2 Nsp3 16-111 500 uM; SARS-CoV-2 Nucleoprotein 191-263 500 uM; sodium phosphate 50 mM; sodium chloride 250 mM; DTT 2 mM; D2O, [U-99% 2H], 10%
sample_conditions_1: pH: 6.5; pressure: 1 atm; temperature: 298.13 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D HNCA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CACB | sample_1 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
3D (H)CCH-TOCSY | sample_4 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_4 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_4 | isotropic | sample_conditions_1 |
3D 1H-13C NOESY aliphatic | sample_4 | isotropic | sample_conditions_1 |
2D 1H-13C HSQC | sample_4 | isotropic | sample_conditions_1 |
2D 1H-1H NOESY | sample_7 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_3 | isotropic | sample_conditions_1 |
3D HNCA | sample_2 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_2 | isotropic | sample_conditions_1 |
3D HNCACB | sample_2 | isotropic | sample_conditions_1 |
3D HN(CO)CACB | sample_2 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_2 | isotropic | sample_conditions_1 |
3D HNCO | sample_2 | isotropic | sample_conditions_1 |
3D HN(CA)CO | sample_2 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_5 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_5 | isotropic | sample_conditions_1 |
3D HCCH-TOCSY | sample_5 | isotropic | sample_conditions_1 |
3D (H)CCH-TOCSY | sample_5 | isotropic | sample_conditions_1 |
2D 1H-13C HSQC | sample_5 | isotropic | sample_conditions_1 |
3D 1H-13C NOESY aliphatic | sample_5 | isotropic | sample_conditions_1 |
2D 1H-13C HSQC | sample_5 | isotropic | sample_conditions_1 |
3D HNCA | sample_6 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_6 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_6 | isotropic | sample_conditions_1 |
2D 1H-13C HSQC | sample_6 | isotropic | sample_conditions_1 |
3D 1H-13C NOESY aliphatic | sample_6 | isotropic | sample_conditions_1 |
3D 1H-15N TOCSY-HSQC | sample_5 | isotropic | sample_conditions_1 |
TOPSPIN v3.5 and 4.1 - collection
NMRFAM-SPARKY v1.3 - chemical shift assignment, data analysis, peak picking
CcpNMR Analysis v2.5 - chemical shift assignment, data analysis, peak picking
NCBI | P0C6X7 P0C6X7 P0DTC9 P0DTC9 P0DTC9 |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks